Nina Bauer

Dr. Nina Bauer is the Global Head of Commercial for the Biologics and Viral Vector CTDMO Business at MilliporeSigma. Nina’s background is in the Cell and Gene Therapy manufacturing space, with prior stints as Lonza’s Head of Autologous Cell Therapy, FloDesign Sonics’ Chief Commercial Officer, and at the Cell and Therapy Catapult in London. She holds an MA in Biology from Stony Brook University (New York), a PhD in Neuroscience from the University of Oldenburg (Germany), and an MBA from the University of Edinburgh (Scotland).